Psoriasis Cream Succeeds in Early Trial

(MedPage Today) -- An investigational, topical cream that inhibits phosphodiesterase type 4 (PDE-4) was effective at clearing plaque psoriasis in a double-blind, phase IIb trial.
Meeting the trial's primary endpoint, 28% of patients treated with...